Ankylosing Spondylitis: A Review

Farrouq Mahmood,1 *Philip Helliwell2

1. Bradford Teaching Hospitals, Bradford, UK
2. Leeds and Bradford Teaching Hospitals, Bradford, UK
*Correspondence to p.helliwell@Leeds.ac.uk

Disclosure: The authors have declared no conflicts of interests.
Received: 28.02.17 Accepted: 15.08.17
Citation: EMJ. 2017;2[4]:134-139.

Abstract

Ankylosing spondylitis is a chronic autoimmune inflammatory condition belonging to the spondyloarthropathy category of rheumatic diseases. It typically affects the axial skeleton but may also present with peripheral arthritis and extra-articular features. Ankylosing spondylitis tends to occur in patients under the age of 45 years, has a higher incidence in males, and can lead to disability and reduced quality of life if not adequately treated. Management consists of a multidisciplinary team approach. Although traditional disease modifying anti-rheumatic drugs are less effective for the axial component of this disease, biologic therapies do seem effective. In severe cases, surgery may be warranted.

This article is made available under the terms of theĀ Creative Commons Attribution-Non Commercial 4.0 License.

Download (PDF, 1.18MB)

Comments are closed.